Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Torrent Pharmaceuticals Ltd. Call Transcript 2024

Jul 29, 2024

61979_rns_2024-07-29_a161e9e0-ff46-459f-9286-8b7a4ae117f0.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [95 x 30] intentionally omitted <==

29[th] July, 2024

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

Mumbai – 400 051

(NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30[th] June, 2024

In continuation of our letter dated 18-Jul-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter ended 30[th] June, 2024, has been placed on the Company’s website at https://www.torrentpharma.com/pdf/investors/Q1-FY24-25_Earnings-Call-Transcript.pdf

Kindly take note of the above.

Thanking you,

Yours Sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN M Digitally signed by CHINTAN M TRIVEDI TRIVEDI Date: 2024.07.29 16:00:05 +05'30' CHINTAN M. TRIVEDI COMPANY SECRETARY

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : [email protected]